Carevive Blog

Events

Carevive Will Be Presenting at 2018 Palliative and Supportive Care In Oncology Symposium

The Carevive team will be attending and presenting a poster at the Palliative and Supportive Care in Oncology Symposium in San Diego. Come to Board B2 to learn more and discuss with Carevive the details and outcomes of this study critical to the ongoing management of cancer patients who have pain. Poster Session A: Communication and Shared Decision Making; Integration and Delivery…
Carevive
November 12, 2018
In The News

Strengthening Bonds in Cancer Care

A startup founded by Penn Nursing grads uses data to improve care management. Originally posted in Penn Nursing. Carevive, a cancer care management and patient engagement platform that provides patients, cancer care teams, and life sciences companies with access to data and insights to improve the quality of care, was founded in 2013 by Penn Nursing graduates Carrie Tompkins Stricker…
Carevive
October 24, 2018
CME

What’s New in Acute Myelogenous Leukemia?

Release date: October 17, 2018 
Expiration date: October 16, 2019 Estimated time to complete activity: 0.75 hours Acute myelogenous leukemia (AML) is a disease of older adults, with a median age of presentation of 67 years; only 5-10% of patients are alive at 5 years. Traditionally older patients have not received intensive induction chemotherapy to avoid toxicities, yet current research shows fit…
Carevive
October 17, 2018
CME

Geriatric Assessment in Older Patients with AML: Treatment Updates and Implications

Release date: October 17, 2018 
Expiration date: October 16, 2019 Estimated time to complete activity: 0.5 hours Acute myelogenous leukemia (AML) is a disease of older adults, with a median age of presentation of 67 years; only 5-10% of patients are alive at 5 years. Traditionally older patients have not received intensive induction chemotherapy to avoid toxicities, yet current research shows fit…
Carevive
October 17, 2018
In The News

Carevive Hires Mordecai Kramer as New Vice President, Data Generation & Outcomes, Life Sciences

  North Miami, FL 10/16/18 — Carevive Systems (https://www.carevive.com) announced today that Mordecai Kramer, MBA has joined the company as Vice President, Data Generation & Outcomes, Life Sciences. In this role, Mordecai will engage with life science companies seeking to generate data from Carevive’s unique patient-reported outcomes (PRO) platform, which will offer them new insights about clinical outcomes within target patient populations.…
Carevive
October 16, 2018
Events

Carevive at Cerner Health Conference 2018

Join Carevive at Cerner Health Conference 2018 Kansas City Convention Center Kansas City, MO October 8-11, 2018 Booth # 507 Carevive will be attending and proudly exhibiting at Cerner Health Conference (CHC) 2018.  CHC 18 is Cerner’s annual conference on the latest innovations in health care and information technology. Carevive will demonstrate its collaborative cancer care management and other oncology tools at…
Carevive
September 27, 2018
Press Releases

Carevive and Cerner integrated cancer care management solution launches at first hospital site

Cloud-based oncology technology company and leader in health care technology mark major milestone with implementation of cancer care planning solution integrated with electronic health record North Miami, Florida — September 19, 2018 — Carevive, a health technology company that builds cancer care management and patient engagement solutions to improve patient quality of life and clinical outcomes, and Cerner, a global…
Carevive
September 19, 2018
In The News

The Patient Voice Is Key to Value-Based Care

Originally posted on Oncology Practice Management by Gail Thompson.  Below is a summary of Carevive's patient engagement plenary session at the #AMCCBS on March 16, 2018. “It’s the disease of not listening that I am troubled with,” a quote attributed to King Henry IV, kicked off a spirited panel discussion on the importance of incorporating the patient’s voice during treatment. Experts…
Carevive
September 1, 2018
Resources

[On-Demand Video] Acute Myelogenous Leukemia: Treatment Updates and Implications for Older Patients

Note: This on-demand video is not available for CME/CNE credit. Acute myeloid leukemia (AML) is a disease of older adults, with a median age of presentation of 67 years; only 5-10% of patients are alive at 5 years. Traditionally older patients have not received intensive induction chemotherapy to avoid toxicities, yet current research shows fit patients treated with intensive chemotherapy…
Carevive
July 25, 2018
CME

Defining What is Value-Based Care for Patients with ​Relapsed/Refractory Chronic Lymphocytic Leukemia​

Defining What is Value-Based Care for Patients with ​Relapsed/Refractory Chronic Lymphocytic Leukemia​​ Release Date: July 6, 2018 Expiration Date:July 6, 2019 ESTIMATED TIME TO COMPLETE ACTIVITY: 150 minutes (2.5 hours)​     TARGET AUDIENCE The target audiences for these activities are hematologists, medical oncologists, pulmonologists, pathologists, physician assistants, nurse practitioners, registered nurses, oncology nurses, nurse navigators, palliative/symptom management teams who care for…
Carevive
July 6, 2018